PAVmed Inc. (PAVM) Tops Q3 EPS by 5c

PAVmed Inc. (NASDAQ: PAVM) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $790 thousand versus the consensus estimate of $658 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• KeyBanc Upgrades Nucor (NUE) to Overweight